ZXP-20135-04673

4 vaccinations 8 coded responses 29 check-ins 8 free-text entries 2 call cases

Sex: —
Age at first dose: 41-45
ZIP prefix: 122 / NY
Registered: 2021-03-05

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
2453602 (opens in a new window)	high	9 / 11	1	1 of 10 VAERS symptoms	same dose (4)	VA differs	2022-09-16 / 2022-09-16 / 2022-09-21 received the same day as the last call	case 1021501

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-05
Registered in v-safe
2021-03-05
Dose 1 — Pfizer-BioNTech
2021-03-05
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain, Swelling · Headache

Adult check-in
2021-03-06
Survey response — days 1–6 daily, dose 1
MedDRA: Vertigo — Feeling: Fair · Site: Pain · Be unable to do your normal daily activities

Free text: Vertigo

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-07
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-03-08
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Headache, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-03-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Diarrhea

Adult check-in
2021-03-10
Survey response — days 1–6 daily, dose 1
MedDRA: Oropharyngeal pain — Feeling: Good

Free text: Sore throat

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-11
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Chills

Adult check-in
2021-03-12
Health check-in — day 7, dose 1
Feeling: Good · Headache

Adult check-in
2021-03-19
Survey response — day 14, dose 1
MedDRA: Inflammation — Feeling: Good · Be unable to do your normal daily activities

Free text: Inflammation

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-26
Dose 2 — Pfizer-BioNTech
2021-03-26
Health check-in — day 0, dose 2
Feeling: Fair · None

Adult check-in
2021-03-27
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-03-28
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Swelling · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-03-29
Survey response — days 1–6 daily, dose 2
MedDRA: Vertigo — Feeling: Good

Free text: Vertigo

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Diarrhea

Adult check-in
2021-03-31
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-02
Health check-in — day 7, dose 2
Feeling: Fair · Headache

Adult check-in
2021-04-09
Survey response — day 14, dose 2
MedDRA: Affect lability — Feeling: Good · Be unable to do your normal daily activities

Free text: Emotional instability

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-16
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-30
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-06-25
Survey response — 3 months, dose 2
MedDRA: Vertigo — Feeling: Fair

Free text: Vertigo

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-09-26
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2021-11-03
Dose 3 — Pfizer-BioNTech
2022-09-16
Dose 4 — Pfizer-BioNTech
Co-administered: Tetanus
2022-09-18
Health check-in — days 1–6 daily, dose 4
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-09-19
Health check-in — days 1–6 daily, dose 4
Feeling: Poor · Site: Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-09-20
Health check-in — days 1–6 daily, dose 4
Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Adult check-in
2022-09-20
Report sent to call center — days 1–6 daily, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-09-21
Call successful
Completed over the phone
2022-09-22
Health check-in — days 1–6 daily, dose 4
Feeling: Poor · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-09-23
Health check-in — day 7, dose 4
Feeling: Fair · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-10-11
Survey response — day 21, dose 4
MedDRA: Ageusia, Anosmia, Cough, Fatigue — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Fatigue, loss of taste and smell, cough.

MedDRA releases: 2024-11 · check-in free text available
2022-10-11
Report sent to call center — day 21, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-10-12
Call 1 — Left Voicemail
2022-10-21
Survey response — day 35, dose 4
MedDRA: Chest discomfort, Cough — Feeling: Fair · Be unable to work or attend school

Free text: Chest tightness, cough

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-05	Pfizer-BioNTech
2	2021-03-26	Pfizer-BioNTech
3	2021-11-03	Pfizer-BioNTech	No
4	2022-09-16	Pfizer-BioNTech	Tetanus

Call center

Reported	Outcome	VAERS-related outcome
2022-09-20	Successful 2022-09-21	Completed over the phone
2022-10-11	Unsuccessful	Reported to VAERS during previous contact from GDIT

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-06

Systemic reaction (other): Vertigo

2021-03-10

Systemic reaction (other): Sore throat

Release 6 — day 14, dose 1

2021-03-19

Symptoms: Inflammation

Release 6 — days 1–6 daily, dose 2

2021-03-29

Systemic reaction (other): Vertigo

Release 7 — day 14, dose 2

2021-04-09

Symptoms: Emotional instability

Release 9 — 3 months, dose 2

2021-06-25

Symptoms: Vertigo

Release 12 — day 21, dose 4

2022-10-11

Symptoms: Fatigue, loss of taste and smell, cough.

Release 12 — day 35, dose 4

2022-10-21

Symptoms: Chest tightness, cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Affect lability	✓	✓	✓
SD	Ageusia	·	·	✓
SD	Anosmia	·	·	✓
SD	Chest discomfort	·	·	✓
SD	Cough	·	·	✓
SD	Fatigue	·	·	✓
SD	Inflammation	✓	✓	✓
SD	Vertigo	✓	✓	✓
SRO	Oropharyngeal pain	✓	✓	✓
SRO	Vertigo	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release